Endotronix, Inc., a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The company's comprehensive solution includes a cloud-based disease management data system and outpatient hemodynamic management with a breakthrough implantable wireless pulmonary artery sensor for early detection of worsening heart failure.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/14/16 | $32,000,000 | Series C |
Aperture Venture Partners Lumira Capital OSF Ventures | undisclosed |
| 09/14/18 | $45,000,000 | Series D |
Aperture Venture Partners BioVentures Investors Lumira Capital OSF Ventures Seroba Life Sciences SV Health Investors Wanxiang | undisclosed |
